Article, Inpatient and Pharmacy Technician

Episode 903: Does the Number of Learners Trained Per Year Influence the Chances of an Inpatient Pharmacist Experiencing Burning Out?

Pharmacy Joe

MARCH 11, 2024

In this episode, I’ll discuss the association between number of learners trained per year and rates of burnout among inpatient pharmacists. Episode 903: Does the Number of Learners Trained Per Year Influence the Chances of an Inpatient Pharmacist Experiencing Burning Out?

Inpatient

Inpatient Pharmacy Technician Hospitals

Episode 903: Does the Number of Learners Trained Per Year Influence the Chances of an Inpatient Pharmacist Experiencing Burning Out?

Pharmacy Joe

MARCH 11, 2024

In this episode, I’ll discuss the association between number of learners trained per year and rates of burnout among inpatient pharmacists. The survey was given to 224 pharmacists and 224 pharmacy technicians. The journal editors added the following 3 key points to take away from the article: 1.

Inpatient

Inpatient Pharmacy Technician Hospitals

Is Pharmacy School Worth it? Part II

The Pharmacist Blog

MARCH 28, 2015

There has been a lot of feedback about my original article “ Is Pharmacy School Worth it? Starting Year 9 both Pharmacy Technician and Pharmacist move out of parents home and significantly increase their cost of living from $8,000 to $30,000 a year. Pharmacy Technician Scenario. Favoring Pharmacist.

Episode 903: Does the Number of Learners Trained Per Year Influence the Chances of an Inpatient Pharmacist Experiencing Burning Out?

Episode 903: Does the Number of Learners Trained Per Year Influence the Chances of an Inpatient Pharmacist Experiencing Burning Out?

Trending Sources

Is Pharmacy School Worth it? Part II

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes

High Response Rates With Talquetamab Plus Teclistamab in Triple-Class Refractory Multiple Myeloma

Review Demonstrates Impaired Quality of Life in Children With Pneumococcal Disease Despite Variations in Study Methodologies

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

Do We Really Pay More for Prescription Drugs in the United States?

Stay Connected